Xilu Wang

USPTO Granted Patents = 52 (Patent Applications = 47)

CIPO Patents = 15 (Patent Applications = 18)

EPO Patents = 23 (Patent Applications = 34)

Average Co-Inventor Count = 9.4

ph-index = 17

Forward Citations = 1,162(Granted Patents)

Forward Citations (Not Self Cited) = 821(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Graylake, IL (US) (2006 - 2008)
Skokie, IL (US) (2004 - 2009)
Oakwood, IL (US) (2011)
Libertyville, IL (US) (2014 - 2023)
Grayslake, IL (US) (2008 - 2024)

Company Filing History:

Abbott Laboratories Corporation

The Walter and Eliza Hall Institute of Medical Research

patents

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

52 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2023-10-17),

3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

4. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2018-09-25),

5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases (2018-01-30),

6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2017-12-19),

7. 9403822 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-08-02),

8. 9359296 - 7-substituted indole Mcl-1 inhibitors (2016-06-07),

9. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-04-05),

10. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-02-23),

11. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-01-05),

12. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-11-03),

13. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-10-13),

14. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-09-08),

15. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-07-07),

Title: Xilu Wang: Pioneering Inventor from Grayslake, IL

Introduction: Xilu Wang is a visionary inventor hailing from Grayslake, Illinois, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xilu Wang holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to creating a more efficient and eco-friendly future.

Career Highlights: With a career spanning over two decades, Xilu Wang has worked with top research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the realm of invention.

Collaborations: Throughout her career, Xilu Wang has collaborated with renowned scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge-sharing.

Conclusion: Xilu Wang's passion for innovation, coupled with her relentless drive to make a positive impact on society, solidifies her status as a trailblazing inventor shaping the future of technology.

This text is generated by artificial intelligence and may not be accurate.